Abstract The World Health Organization classification and definition of “myeloid sarcoma” is
imprecise and misleading. A more accurate term is “extramedullary acute myeloid leukemia …

Myeloid sarcoma is a rare disease that can present as an isolated extramedullary leukemic
tumor, concurrently with or at relapse of acute myeloid leukemia. Owing to the rarity of this …

Extramedullary (EM) manifestations of acute leukemia include a wide variety of clinically
significant phenomena that often pose therapeutic dilemmas. Myeloid sarcoma (MS) and …

Myeloid sarcoma (MS) is a rare neoplasm whose knowledge is largely based on case
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …

Granulocytic sarcoma also called myeloid sarcoma is an extramedullary tumor of immature
granulocytic cells. It is a rare entity, and mostly accompanied by acute myeloid leukemia. It is …

BACKGROUND. It is unknown whether patients with nonleukemic myeloid sarcoma (MS)
and those with acute myeloid leukemia (AML) have similar responses to anti‐AML treatment …

Purpose: To investigate the possible prognostic factors of survival outcomes in patients with
granulocytic sarcoma (GS). Methods: We retrospectively investigated the prognostic factors …

Myeloid sarcoma (MS) is an extramedullary tumor of immature myeloid cells. We analyzed
131 patients with MS, including:(1) de novo MS;(2) MS with concomitant acute myeloid …

Abstract Context.-Myeloid sarcoma (MS) is a neoplasm of immature granulocytes,
monocytes, or both involving any extramedullary site. The correct diagnosis of MS is …

Myeloid sarcoma : Current Opinion in Hematology Myeloid sarcoma : Current Opinion in
Hematology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …